Search Within

Andrea C. Levoir

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Clinical Pharmacy Specialists (6)
  2. Center for Hematologic Malignancies (5)
  3. Department of Medicine (5)
  4. Hematologic Malignancies, Division of (5)
  5. Lymphoma (5)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Michael Buege (6)
  2. Phuong Dao (6)
  3. Terry Pak (6)
  4. Esther Drill (4)
  5. Tim Peterson (4)
  6. David Straus (3)

More People

Years
  1. 2023 (1)
  2. 2021 (5)
  3. 2020 (1)
Publications
  1. Blood (2)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)
  3. European Journal of Haematology (1)
  4. Hematological Oncology (1)
  5. Journal of Oncology Pharmacy Practice (1)
  6. Journal of Pain and Symptom Management (1)
Publishers
  1. American Society of Hematology (2)
  2. Elsevier Inc. (2)
  3. John Wiley & Sons (1)
  4. Sage Publications Ltd. (1)
  5. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure
    Journal Article

    Buege, M. J.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Dao, P. H.; Matasar, M. J.
    European Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Chronic opioid therapy in cancer survivors at a specialty oncology pain clinic: Opioid dosing, efficacy, and safety during five years of pain management
    Journal Article

    LeVoir, A.; Lee, M.; Fitzgibbon, D.; Hsu, M.; Posner, K.
    Journal of Pain and Symptom Management (2021)

    Fulltext@MSK | Save
  • Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
    Journal Article

    Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
    Journal of Oncology Pharmacy Practice (2021)

    Fulltext@MSK | Save
  • IVAC +/- R for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A. C.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Blood (2020)

    Fulltext@MSK | Save